Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

PATIENTS TREATED WITH RLF-100 IV SHOULD HAVE THEIR BRAINS CHECKED

Jan. 25, 2021 -- The coronavirus may remain in people’s brains after infection and trigger relapses in patients who thought they had recovered, according to a new study published in the journal Viruses.

In the study, mice that were infected with the virus through their nasal passages developed severe illnesses due to brain infections, even after the virus left their lungs. In humans, this could explain why patients who appear to be over COVID-19 sometimes relapse and die.

https://www.webmd.com/lung/news/20210125/covid-19-may-hide-in-brains-and-cause-relapses